Skip to main content
Clinical Trials/NCT05163015
NCT05163015
Unknown
Not Applicable

Impact of Oncogeriatric Consultation on Quality of Life of Patients Aged 75 and More With Cancer

Université de Reims Champagne-Ardenne1 site in 1 country60 target enrollmentJanuary 4, 2022
ConditionsCancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
Université de Reims Champagne-Ardenne
Enrollment
60
Locations
1
Primary Endpoint
EORTC QLQ-C30
Last Updated
4 years ago

Overview

Brief Summary

Among patients with cancer, 6 in 10 are over 65 years of age. In order to improve quality of life of aged cancer patients, the oncogeriatric consultation has been created. Oncogeriatric consultation aim to help oncologists determine the best solutions to combine therapy and quality of life. Factors influencing quality of life of cancer patients have been studied previously. However, these studies always focus on one specific cancer.

Detailed Description

The aim of the study is to study factors associated with quality of life in patients aged 75 and more with cancer, notably the oncogeriatric consultation.

Registry
clinicaltrials.gov
Start Date
January 4, 2022
End Date
August 1, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Université de Reims Champagne-Ardenne
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • male or female
  • aged of 75 and more
  • with cancer
  • with indication of oncogeriatric consultation according G8
  • agreeing to participate in the study

Exclusion Criteria

  • less than 75 years old

Outcomes

Primary Outcomes

EORTC QLQ-C30

Time Frame: Day 60

The QLQ-C30 is a generic questionnaire with 30 questions coded in 4 response modalities (not at all (1), a little (2), enough (3), a lot (4)) or in 7 response modalities (from very bad (1) to excellent ( 7)). Questions are summarized in five multiitem domains (physical, role, cognitive, emotional, and social functioning) and nine single item domains (fatigue, pain, nausea/vomiting, appetite loss, financial impact; diarrhea, constipation, sleep disturbance and quality of life). Each domain is scored between 0 and 100. For functional domains, a high score value represents a high level of quality of life. For symptom domains, a high score represents an important level of symptoms (a low level of quality of life).

Study Sites (1)

Loading locations...

Similar Trials